Swarn Artificial Aids Private Limited
About Swarn Artificial Aids Private Limited
Data last updated:
Swarn Artificial Aids Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 29 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U93000DL2007PTC164055.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajbala Rani and Satish Kumar Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T – 2321 Faiz Road Karol Bagh, New Delhi, Delhi, India – 110005.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.01 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹5.5 Lakh (net margin 78.5%) and EBITDA of ₹6.82 Lakh (EBITDA margin 97.3%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Swarn Artificial Aids Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressT – 2321 Faiz Road Karol Bagh, New Delhi, Delhi, India – 110005
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Swarn Artificial Aids Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Swarn Artificial Aids Private Limited
FY 2025 filings availableSwarn Artificial Aids Private Limited reported revenue of ₹7.01 Lakh (down 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 21% fall in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 97.3% | ||||
| Net Profit Margin | 78.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Swarn Artificial Aids Private Limited, buy the company report.
Board of directors of Swarn Artificial Aids Private Limited
Swarn Artificial Aids has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajbala Rani | Director | 14 Aug 2008 | 18 Years 2 Months | Current |
| Satish Kumar Goel | Director | 14 Aug 2008 | 18 Years 2 Months | Current |
Peer comparison
Swarn Artificial Aids Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tranchant Foods and Exports Private Limited | ₹7.15 Lakh (FY 2025) | 318977.0% | Ernakulam, Kerala, India | |||
| Omiracle Life Care Private Limited | ₹7.12 Lakh (FY 2025) | 79.0% | Ghatlodia, Ahmedabad, Gujarat, India | |||
| Scineers Scientific India Private Limited | ₹7.1 Lakh (FY 2025) | Dombivli, Maharashtra, India | ||||
| Cera Global Spine Care Private Limited | ₹7.06 Lakh (FY 2023) | 131.0% | Sonipat, Haryana, India | |||
| Liveliness Healthcare Private Limited | ₹7.05 Lakh (FY 2022) | -56.0% | Indore, Madhya Pradesh, India | |||
| Swarn Artificial Aids Private Limitedthis company | ₹7.01 Lakh (FY 2025) | ₹5.5 Lakh | 78.5% | -21.0% | New Delhi, Delhi, India | |
| Chemedix India Private Limited | ₹7.01 Lakh (FY 2024) | -62.0% | Jalgaon, Maharashtra, India | |||
| Kamroph Guardian Medz Private Limited | ₹6.99 Lakh (FY 2021) | 85.0% | New Delhi, Delhi, India | |||
| NTP Healthcare & Medical Services Private Limited | ₹6.98 Lakh (FY 2025) | -13.0% | Delhi, India | |||
| Solana Marketing Private Limited | ₹6.96 Lakh (FY 2025) | 47.0% | Palakkad, Kerala, India | |||
| Us Medi-Equip & Furniture Private Limited | ₹6.96 Lakh (FY 2024) | -69.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Swarn Artificial Aids Private Limited, buy the company report.
Auditor
Swarn Artificial Aids Private Limited is audited by P N ARORA & CO for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P N ARORA & CO | FY 2016 | 008883C |
Shareholding
The shareholding of Swarn Artificial Aids Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Swarn Artificial Aids Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Swarn Artificial Aids Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Swarn Artificial Aids Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Swarn Artificial Aids Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Swarn Artificial Aids Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Kulbhushan Madhok ceased to be Director on 01 Dec 2011.
Frequently asked questions
Swarn Artificial Aids is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 29 May 2007 (19+ years old) and is registered under CIN U93000DL2007PTC164055.
Swarn Artificial Aids has 2 current directors:
- Rajbala Rani - Director
- Satish Kumar Goel - Director
The latest financial statements of Swarn Artificial Aids on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Swarn Artificial Aids is U93000DL2007PTC164055. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swarn Artificial Aids was incorporated on 29 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Swarn Artificial Aids by revenue are Tranchant Foods and Exports Private Limited, Omiracle Life Care Private Limited, Scineers Scientific India Private Limited, Cera Global Spine Care Private Limited, Liveliness Healthcare Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Kulbhushan Madhok ceased to be Director on 01 Dec 2011. Swarna Madhok ceased to be Director on 01 Dec 2011. Nitin Mehta ceased to be Director on 19 Aug 2008. Swarn Artificial Aids has 6 board changes on record in total.
The registered office of Swarn Artificial Aids is at T – 2321 Faiz Road Karol Bagh, New Delhi, Delhi, India – 110005.
Swarn Artificial Aids operates in the healthcare industry, in the medical equipment retail and distribution segment.
The compliance status of Swarn Artificial Aids is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.
Swarn Artificial Aids can be reached at its registered office: T – 2321 Faiz Road Karol Bagh, New Delhi, Delhi, India – 110005.